Diagnostics startup Theranos is seeking a laboratory director to oversee one of its key facilities amid questions raised in laboratory circles about the qualifications of a physician who now runs the lab.
A Food and Drug Administration advisory panel overwhelmingly called for heightened label warnings on widely prescribed antibiotics called fluoroquinolones because of unusual but sometimes devastating side effects.
In a sign of growing government interest in rising prescription-drug costs, federal officials said state Medicaid programs may be violating federal law by denying patients expensive hepatitis C medications.
A novel gene-editing technique has been used to eliminate an infant’s aggressive cancer, a small but significant step in the quest to treat deadly diseases by altering the human genome.
Myriad Genetics on Tuesday reported higher first-quarter profit as sales of its DNA tests rose nearly 9%.
GlaxoSmithKline PLC’s Nucala therapy has been approved to treat patients with severe asthma attacks in combination with other drugs, the Food and Drug Administration said Wednesday.
Mylan has agreed to sell the rights and assets related to seven generic drugs to secure regulatory approval of its hostile takeover of Perrigo.
Authorities have identified the strain of E. coli in an outbreak linked to Chipotle Mexican Grill and it isn’t the most severe form of the bacteria, state health officials said Tuesday.
Drug overdoses in New Hampshire are on track to break last year’s record. The pattern is so alarming that participants in an October poll ranked drug abuse as the most important issue in the 2016 presidential campaign—prompting a conversation that is remarkably different from prior elections.
WebMD Health reported higher third-quarter profit, driven by better-than-expected revenue growth and an increase in traffic.
CureVac Tuesday said a group of investors bought a stake in the German drug developer for 98.5 million euros ($108.5 million), valuing the company at €1.5 billion.
Federal penalties for workplace-safety violations were increased this week for the first time since 1990, thanks to a little-noticed provision of the budget bill signed into law by President Barack Obama.
White middle-aged Americans are dying at an increasing rate, a new analysis of government data shows, a startling turnaround suggesting a rising toll of addiction and mental-health issues is reversing decades of gains in longevity.
Shire has struck an all-cash deal valued at as much as $6.5 billion for U.S. biotech firm Dyax, continuing to pursue midsize acquisitions even as it chases a $30 billion deal for Baxalta.
An E. coli outbreak linked to Chipotle Mexican Grill restaurants in two states is another setback for a company whose long success marketing healthful fare has recently hit slower growth and increased competition.
Xylitol, a sugar substitute used in chewing gum and other products, is causing a surge in accidental poisonings of dogs, some fatal. The sweetener is roughly 100 times as toxic to dogs as milk chocolate, experts say.
Philidor Rx Services LLC said Monday that it has begun to wind down operations following a tumultuous period that saw its principal client and largest pharmacy-benefit managers end relations with the mail-order pharmacy.
With the Affordable Care Act’s third open-enrollment season now under way, many health insurers are recalibrating their approach—and raising premiums—having seen that an influx of new membership often doesn’t translate into profit.
There is a new price surge in the pharmaceutical industry—for a limited number of government-issued vouchers that drug makers, including AbbVie and Sanofi, are buying to speed products to market.
Researchers study how increasing awareness of genetics and health histories affects financial planning.